About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,742 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,742 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4901-4920 of 17,742 trials

CompletedEffects of Chronic Antihypertensive Therapy on Clinical Outcomes in Septic ShockRetrospective two-cohort study to determine the effect of chronic antihypertensive therapy on new onset atrial fibrillation and clinical outcomes in septic shock.NCT02876341·Chicago, Illinois CompletedCytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid LeukemiaRATIONALE: Drugs used in chemotherapy, such as cytarabine and VNP40101M, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them…NCT00112554·Los Angeles, California and 61 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

UnknownComparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral TherapyThe purpose of this study is to compare GW433908 and nelfinavir when each is given with abacavir and lamivudine to HIV patients who have not taken antiretroviral drugs.NCT00008554·Concord, California and 22 others

CompletedEvaluation of Multisensor Data in Heart Failure Patients With Implanted DevicesThe goal of the MultiSENSE study is to collect chronic information from multiple sensors in an implanted device for evaluation in heart failure patients.NCT01128166·Anchorage, Alaska and 98 others

CompletedThe Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseThis study evaluated the safety and effectiveness of AA4500 in improving the impact of Peyronie's disease on quality of life and improving penile curvature in men with Peyronie's…NCT00755222·Burbank, California and 11 others

CompletedA Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection.NCT04649151·Banning, California and 52 others

CompletedA Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected InfantsTo assess whether HIV-infected infants who receive a heptavalent pneumococcal conjugate vaccine have more local reactions at the site of injection and systemic reactions than…NCT00000829·Los Angeles, California and 32 others

CompletedPomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsThis phase I trial studies the side effects and best dose of pomalidomide in treating younger patients with tumors of the brain or spine (central nervous system) that have come…NCT02415153·Los Angeles, California and 11 others

TerminatedA Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve BlockThe purpose of this study is to compare the incidence of postoperative symptoms of neurologic injury after a single shot infragluteal-parabiceps sciatic nerve block versus a…NCT01615939·Chicago, Illinois

TerminatedA Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid TumorsA multicenter trial to investigate TBio-4101, an autologous, neoantigen-selected, tumor-reactive TIL product, in patients with advanced solid malignancies.NCT05576077·Irvine, California and 12 others

Active not recruitingA Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple MyelomaThis is a study of venetoclax, daratumumab, and dexamethasone with and without bortezomib combination therapy to evaluate safety, tolerability, and efficacy of these combinations…NCT03314181·Aurora, Colorado and 39 others

CompletedPhantom Motor Execution Via MPR, VR/AR, and SG, as a Treatment of PLPThis international, multi-center, double-blind, randomized, controlled clinical trial aims to evaluate the efficacy of Phantom Motor Execution (PME) and Phantom Motor Imagery…NCT03112928·Chicago, Illinois and 8 others

CompletedInorganic Nitrite Delivery to Improve Exercise Capacity in HFpEFA randomized, double-blind, placebo-controlled crossover study to assess the effect of inorganic nitrite (NO2) on aerobic capacity (peak VO2) after four weeks of dosing.NCT02742129·Atlanta, Georgia and 19 others

CompletedStudy of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer PatientsAn open-label, multicenter, randomized, Phase 2 trial in which participant with unresectable, locally advanced or metastatic breast cancer who have been previously treated with…NCT01234402·Scottsdale, Arizona and 22 others

CompletedSafety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell LymphomaAn open-label, multi-dose, single-arm, Phase 1 dose escalation study of XmAb®2513 was conducted to define the MTD or recommended dose(s) for further study, to determine safety and…NCT00606645·Chicago, Illinois and 3 others

CompletedEvaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19This is a randomized, double-blind, sham controlled, stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older…NCT05817045·Mesa, Arizona and 47 others

CompletedEfficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With AcromegalyThe purpose of this study is to compare the effectiveness of lanreotide autogel to placebo after a single injection.NCT00234572·Birmingham, Alabama and 28 others

CompletedBehavioral Intervention for HIV and HCV-Uninfected Injection Drug UsersThe purpose of this study is to test whether a six-session behavioral intervention for HIV and HCV seronegative injection drug users is effective in reducing sexual and injection…NCT00164372·Los Angeles, California and 4 others

TerminatedSafety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of MetforminThe purpose of this study is to demonstrate the efficacy of dutogliptin over 26 weeks (as evidenced by placebo-corrected changes in HbA1c relative to baseline), to demonstrate…NCT00850239·Montgomery, Alabama and 96 others

Active not recruitingA 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughThis is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).NCT05600777·Foley, Alabama and 241 others

PreviousPage 246 of 888Next

in Chicago

Heart Diseasein Chicago